Daniel S. Budnitz

9.7k total citations · 6 hit papers
70 papers, 6.7k citations indexed

About

Daniel S. Budnitz is a scholar working on Emergency Medicine, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Daniel S. Budnitz has authored 70 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Emergency Medicine, 25 papers in Geriatrics and Gerontology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Daniel S. Budnitz's work include Pharmaceutical Practices and Patient Outcomes (25 papers), Poisoning and overdose treatments (20 papers) and Pharmaceutical studies and practices (17 papers). Daniel S. Budnitz is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (25 papers), Poisoning and overdose treatments (20 papers) and Pharmaceutical studies and practices (17 papers). Daniel S. Budnitz collaborates with scholars based in United States, Uganda and Malta. Daniel S. Budnitz's co-authors include Nadine Shehab, Maribeth C. Lovegrove, Chesley Richards, Andrew I. Geller, Scott R. Kegler, Leonard J. Paulozzi, Daniel A. Pollock, Nina J. Weidle, Joseph L. Annest and Aaron B. Mendelsohn and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel S. Budnitz

68 papers receiving 6.4k citations

Hit Papers

Emergency Hospitalizations for Adverse Drug Events in Old... 2006 2026 2012 2019 2011 2006 2006 2016 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Emergency Hospitalizations for Adverse Drug Events in Older Americans
    2011 1.3k citations Daniel S. Budnitz, Maribeth C. Lovegrove et al. New England Journal of Medicine profile →
  2. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events
    2006 657 citations Daniel S. Budnitz, Daniel A. Pollock et al. profile →
  3. Increasing deaths from opioid analgesics in the United States
    2006 547 citations Daniel S. Budnitz et al. Pharmacoepidemiology and Drug Safety profile →
  4. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
    2016 466 citations Nadine Shehab, Maribeth C. Lovegrove et al. profile →
  5. Emergency Department Visits for Adverse Events Related to Dietary Supplements
    2015 321 citations Andrew I. Geller, Nadine Shehab et al. New England Journal of Medicine profile →
  6. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
    2021 189 citations Minn Soe, Hsiu Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel S. Budnitz United States 33 2.1k 1.1k 946 927 805 70 6.7k
Daniel C. Malone United States 42 2.2k 1.1× 842 0.7× 1.0k 1.1× 826 0.9× 281 0.3× 298 8.0k
David W. Bates United States 38 2.0k 1.0× 618 0.5× 1.1k 1.2× 856 0.9× 936 1.2× 98 10.3k
Nadine Shehab United States 27 1.5k 0.7× 715 0.6× 986 1.0× 304 0.3× 375 0.5× 42 5.1k
David C. Classen United States 46 2.9k 1.4× 1.1k 1.0× 1.0k 1.1× 850 0.9× 606 0.8× 142 11.2k
Sean Hennessy United States 50 746 0.4× 567 0.5× 1.2k 1.3× 973 1.0× 365 0.5× 268 8.7k
Anton Pottegård Denmark 46 1.0k 0.5× 991 0.9× 1.5k 1.5× 1.1k 1.2× 286 0.4× 385 10.0k
Elizabeth E. Roughead Australia 46 3.4k 1.6× 846 0.8× 1.1k 1.2× 984 1.1× 245 0.3× 324 8.5k
Michael A. Steinman United States 48 2.3k 1.1× 737 0.7× 1.1k 1.2× 897 1.0× 342 0.4× 214 8.3k
Jesper Hallas Denmark 61 2.1k 1.0× 1.7k 1.5× 3.5k 3.7× 1.4k 1.5× 646 0.8× 476 17.4k
Andrew J. McLachlan Australia 64 3.6k 1.8× 1.5k 1.3× 1.5k 1.6× 1.2k 1.3× 373 0.5× 450 15.5k

Countries citing papers authored by Daniel S. Budnitz

Since Specialization
Citations

This map shows the geographic impact of Daniel S. Budnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Budnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Budnitz more than expected).

Fields of papers citing papers by Daniel S. Budnitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Budnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Budnitz. The network helps show where Daniel S. Budnitz may publish in the future.

Co-authorship network of co-authors of Daniel S. Budnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Budnitz. A scholar is included among the top collaborators of Daniel S. Budnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Budnitz. Daniel S. Budnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Budnitz, Daniel S., et al.. (2024). A Pilot Study Assessing Common Medication Organizers for Child-Resistant Features. SHILAP Revista de lepidopterología. 3(4). 100232–100232.
2.
Lovegrove, Maribeth C., Nina J. Weidle, Andrew I. Geller, et al.. (2023). Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures. American Journal of Preventive Medicine. 64(6). 834–843. 3 indexed citations
3.
Alexander, G. Caleb, Daniel S. Budnitz, Carmel Hughes, et al.. (2023). Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023. Drug Safety. 47(1). 103–111.
4.
Geller, Andrew I., Daniel S. Budnitz, Heather Dubendris, et al.. (2022). Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021. Public Health Reports. 137(2). 239–243. 6 indexed citations
5.
6.
Gouin, Katryna A., Lauri A. Hicks, Jennifer N. Lind, et al.. (2021). Trends in Prescribing of Antibiotics and Drugs Investigated for Coronavirus Disease 2019 (COVID-19) Treatment in US Nursing Home Residents During the COVID-19 Pandemic. Clinical Infectious Diseases. 74(1). 74–82. 17 indexed citations
7.
Lovegrove, Maribeth C., Robert J. Geller, Adam C. Pomerleau, et al.. (2020). Circumstances Involved in Unsupervised Solid Dose Medication Exposures among Young Children. The Journal of Pediatrics. 219. 188–195.e6. 10 indexed citations
8.
Moro, Ruth N., Andrew I. Geller, Nina J. Weidle, et al.. (2020). Emergency Department Visits Attributed to Adverse Events Involving Benzodiazepines, 2016–2017. American Journal of Preventive Medicine. 58(4). 526–535. 14 indexed citations
9.
Geller, Andrew I., Deborah Dowell, Maribeth C. Lovegrove, et al.. (2019). U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016. American Journal of Preventive Medicine. 56(5). 639–647. 21 indexed citations
10.
Geller, Andrew I., Maribeth C. Lovegrove, Nadine Shehab, et al.. (2018). National Estimates of Emergency Department Visits for Antibiotic Adverse Events Among Adults—United States, 2011–2015. Journal of General Internal Medicine. 33(7). 1060–1068. 40 indexed citations
11.
Lovegrove, Maribeth C., et al.. (2017). Primary Care Provider Perceptions and Practices Regarding Dosing Units for Oral Liquid Medications. Academic Pediatrics. 18(4). 405–408. 3 indexed citations
12.
Geller, Andrew I., Nadine Shehab, Nina J. Weidle, et al.. (2015). Emergency Department Visits for Adverse Events Related to Dietary Supplements. New England Journal of Medicine. 373(16). 1531–1540. 321 indexed citations breakdown →
13.
Manthripragada, Angelika D., Esther H. Zhou, Daniel S. Budnitz, Maribeth C. Lovegrove, & Mary E. Willy. (2011). Characterization of acetaminophen overdose‐related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and Drug Safety. 20(8). 819–826. 62 indexed citations
14.
Budnitz, Daniel S., Maribeth C. Lovegrove, & Alexander E. Crosby. (2011). Emergency Department Visits for Overdoses of Acetaminophen-Containing Products. American Journal of Preventive Medicine. 40(6). 585–592. 144 indexed citations
15.
Budnitz, Daniel S., Maribeth C. Lovegrove, Nadine Shehab, & Chesley Richards. (2011). Emergency Hospitalizations for Adverse Drug Events in Older Americans. New England Journal of Medicine. 365(21). 2002–2012. 1268 indexed citations breakdown →
16.
Classen, David C., et al.. (2010). Adverse Drug Events Among Hospitalized Medicare Patients: Epidemiology and National Estimates from a New Approach to Surveillance. The Joint Commission Journal on Quality and Patient Safety. 36(1). 12–AP9. 71 indexed citations
17.
Shehab, Nadine, Priti R. Patel, Arjun Srinivasan, & Daniel S. Budnitz. (2008). Emergency Department Visits for Antibiotic‐Associated Adverse Events. Clinical Infectious Diseases. 47(6). 735–743. 399 indexed citations
18.
Cohen, Adam L., Daniel S. Budnitz, Daniel B. Jernigan, et al.. (2007). National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events in Children and Adolescents. The Journal of Pediatrics. 152(3). 416–421.e2. 81 indexed citations
19.
20.
Budnitz, Daniel S. & Peter M. Layde. (2006). Outpatient drug safety: new steps in an old direction. Pharmacoepidemiology and Drug Safety. 16(2). 160–165. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel C. Malone Breakdown of academic impact, for papers by David W. Bates Breakdown of academic impact, for papers by Nadine Shehab Breakdown of academic impact, for papers by David C. Classen Breakdown of academic impact, for papers by Sean Hennessy Breakdown of academic impact, for papers by Anton Pottegård Breakdown of academic impact, for papers by Elizabeth E. Roughead Breakdown of academic impact, for papers by Michael A. Steinman Breakdown of academic impact, for papers by Jesper Hallas Breakdown of academic impact, for papers by Andrew J. McLachlan
Rankless by CCL
2026